4//SEC Filing
Ryll Thomas 4
Accession 0001179110-20-001425
CIK 0000855654other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 9:24 AM ET
Size
5.4 KB
Accession
0001179110-20-001425
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Ryll Thomas
VP, Technical Operations
Transactions
- Award
Stock Option (right to buy)
2020-02-07$4.55/sh+222,300$1,011,465→ 222,300 totalExercise: $4.55From: 2021-02-07Exp: 2030-02-07→ Common Stock (222,300 underlying)
Footnotes (1)
- [F1]25% of the options are exercisable on the first year anniversary of the grant and the balance is exercisable in twelve equal installments of 6.25%, quarterly over the following three years starting one quarter after the first year anniversary.
Documents
Issuer
ImmunoGen, Inc.
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001701531
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 9:24 AM ET
- Size
- 5.4 KB